Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 40.65B P/E 39.19 EPS this Y 8.90% Ern Qtrly Grth 106.60%
Income 1.36B Forward P/E 18.79 EPS next Y 13.00% 50D Avg Chg 2.00%
Sales 14.98B PEG 1.83 EPS past 5Y 15.24% 200D Avg Chg 5.00%
Dividend N/A Price/Book 6.98 EPS next 5Y 11.48% 52W High Chg -12.00%
Recommedations 1.90 Quick Ratio 0.76 Shares Outstanding 182.01M 52W Low Chg 32.00%
Insider Own 0.92% ROA 4.98% Shares Float 179.80M Beta 1.52
Inst Own 92.29% ROE 22.87% Shares Shorted/Prior 2.85M/3.20M Price 219.09
Gross Margin 34.96% Profit Margin 9.06% Avg. Volume 1,086,056 Target Price 276.35
Oper. Margin 13.65% Earnings Date Jul 30 Volume 1,079,121 Change -0.02%
About IQVIA Holdings, Inc.

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

IQVIA Holdings, Inc. News
08:40 AM Here's Why IQVIA Holdings (IQV) is a Strong Value Stock
02:32 AM IQVIA Holdings Inc (IQV) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
12:05 AM Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight
05/02/24 Q1 2024 IQVIA Holdings Inc Earnings Call
05/02/24 IQVIA (IQV) Surpasses Earnings & Revenue Estimates in Q1
05/02/24 IQVIA Holdings Inc (IQV) First Quarter 2024 Earnings: Surpasses Revenue Estimates
05/02/24 IQVIA Holdings (IQV) Tops Q1 Earnings and Revenue Estimates
05/02/24 An Intrinsic Calculation For IQVIA Holdings Inc. (NYSE:IQV) Suggests It's 30% Undervalued
05/02/24 IQVIA Reports First-Quarter 2024 Results
04/29/24 IQVIA (IQV) to Report Q1 Earnings: What's in the Offing?
04/29/24 Countdown to IQVIA (IQV) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
04/25/24 20 Fastest Growing Health Tech Companies in the World
04/25/24 IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth
04/24/24 10 Stocks Hedge Funds Are Talking About
04/24/24 Insiders At IQVIA Holdings Sold US$10m In Stock, Alluding To Potential Weakness
04/23/24 IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards
04/20/24 Should You Be Adding IQVIA Holdings (NYSE:IQV) To Your Watchlist Today?
04/18/24 19 Best Alternatives to Discord in 2024
04/17/24 Reasons to Retain IQVIA (IQV) Stock in Your Portfolio Now
04/16/24 IQVIA Holdings (NYSE:IQV) Seems To Use Debt Quite Sensibly
IQV Chatroom

User Image Tokenist Posted - 1 day ago

🚨EARNINGS ALERT🚨 Notable earnings released for today: Cigna $CI: $6.47 EPS vs $6.22 est. / $57.26B Revenue vs $56.6B est. WestRock Co $WRK: $0.39 EPS vs $0.24 est. / $4.73M Revenue vs $4.75B est IQVIA Holdings $IQV: $2.54 EPS vs $2.48 est. / $3.74B Revenue vs $3.7B est

User Image Estimize Posted - 1 day ago

$IQV reports inline with the Estimize EPS Consensus and beats the Estimize Revenue Consensus by $19.26M. Reports FQ1 earnings of $2.54 ... http://www.estimize.com/iqv/fq1-2024?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image epsguid Posted - 1 day ago

$IQV reported earnings of $2.54, consensus was $2.38, Earnings Whisper was $2.55 via @eWhispers #whispermiss http://eps.sh/d/iqv

User Image Stock_Titan Posted - 1 day ago

$IQV IQVIA Reports First-Quarter 2024 Results https://www.stocktitan.net/news/IQV/iqvia-reports-first-quarter-2024-l52za1cs0n70.html

User Image Estimize Posted - 1 day ago

$IQV reports before the open tomorrow, Estimize Consensus +0.06 EPS and +18.68M Revs compared to WS http://www.estimize.com/iqv/fq1-2024?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

User Image WhisperNumber Posted - 04/23/24

$TMO #earnings before open Wed, the expectation from the WhisperNumber community is $4.75, 4c ahead of analyst estimates. Earnings came in $0.15 short of the whisper last quarter. 52% beat rate. Implied movement +/-5.1%. https://www.whispernumber.com/wr_options_alerts.jsp #options $DHR $IQV

User Image John_Wick1234 Posted - 04/18/24

$IQV Ascending Channel

User Image John_Wick1234 Posted - 04/17/24

$IQV Ascending Channel

User Image Stock_Titan Posted - 04/15/24

$IQV IQVIA to Announce First-Quarter 2024 Results on May 2, 2024 https://www.stocktitan.net/news/IQV/iqvia-to-announce-first-quarter-2024-results-on-may-2-q24ta1vohn7x.html

User Image DonCorleone77 Posted - 04/08/24

$IQV $CRM 2 of 2 - Iqvia, Salesforce expand global partnership ...IQVIA will continue to market the OCE CRM product and will support its nearly 400 global OCE customers in 130+ countries through 2029. IQVIA will work with Salesforce to jointly market the new offering. The two companies will bring together talent, technology and expertise to ensure a coordinated transition from IQVIA's OCE to Salesforce's next generation life sciences solution. "Our expanded relationship with Salesforce will bring the best of our combined capabilities in data, AI and technology to life sciences customers. In collaboration with various strategic partners across multiple healthcare verticals, IQVIA will continue to develop innovative technology solutions to help accelerate decision making across discovery, clinical development, medical affairs, real world evidence generation, patient safety, regulatory compliance, patient engagement and commercial operations," said Bernd Haas, SVP.

User Image DonCorleone77 Posted - 04/08/24

$IQV $CRM 1 of 2 - Iqvia, Salesforce expand global partnership Iqvia (IQV) and Salesforce (CRM) announced an expanded global strategic partnership to accelerate the development of Salesforce's Life Sciences Cloud, a next-generation customer engagement platform for the global life sciences industry. Building on the IQVIA Orchestrated Customer Engagement platform, launched in 2017, the partnership will apply innovations from IQVIA OCE with Salesforce's Life Sciences Cloud to provide customers with a new single, end-to-end engagement platform. Salesforce's leading CRM software, powered by IQVIA data, domain expertise and advanced analytics, is expected to transform healthcare professional and patient engagement. As part of the expanded partnership, IQVIA will license the OCE CRM related software to Salesforce, and the parties will collaborate to accelerate development of Life Sciences Cloud for customer engagement, expected to be available in 2025....

User Image Stock_Titan Posted - 04/08/24

$IQV $CRM IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud https://www.stocktitan.net/news/IQV/iqvia-and-salesforce-expand-global-partnership-to-accelerate-the-dgkypzs17gk9.html

User Image Nelsin Posted - 03/22/24

$IQV Buy to Open. Target: $278.15

User Image Stock_Titan Posted - 03/06/24

$IQV IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024 https://www.stocktitan.net/news/IQV/iqvia-cfo-ron-bruehlman-to-speak-at-barclays-annual-global-5h4d30rver6z.html

User Image Wigglyick Posted - 03/06/24

$IQV Advanced analytics for the life science’s industry. Rising wedge, which way will it break ?

User Image Immortal_VXRT_bull Posted - 2 months ago

$IQV Very small exposure but is Investor in belong.life https://hitconsultant.net/2024/02/28/belong-life-launches-conversational-ai-cancer-mentor/

User Image swingingtech Posted - 02/27/24

$IQV https://wallstreetwaves.com/leerink-partners-initiates-coverage-of-iqvia-holdings-iqv-with-outperform-recommendation/

User Image TickerDD_com Posted - 02/26/24

From 2/16/2024, looking back across 22 Month-Ends for IQV, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had More Positives (91%) $IQV #IQV #IQVStock #TickerDD #IQVPrice https://www.youtube.com/watch?v=iOXc2ZL5cPY

User Image Stock_Titan Posted - 02/26/24

$IQV IQVIA Publishes its 2023 Environmental, Social and Governance Report https://www.stocktitan.net/news/IQV/iqvia-publishes-its-2023-environmental-social-and-governance-06w9uq7f1zvw.html

User Image Wigglyick Posted - 02/25/24

@HostileCharts I’m in, been a good one. I like $IQV also. Good luck

User Image Wigglyick Posted - 02/25/24

@JFDI welcome back, hope the vaca was good ! $IQV

User Image Wigglyick Posted - 02/25/24

$IQV Provides services to Life Sciences industry, technical & analytical. No position yet. Less than 1k watchers. Good luck.

User Image Stock_Titan Posted - 02/23/24

$IQV Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report https://www.stocktitan.net/news/IQV/global-biopharma-r-amp-d-boasts-increased-funding-productivity-and-p5nv5mgwna4p.html

User Image RallyRaider Posted - 02/22/24

$IQV great action. did they finally start saying AI? i feel like they are one of the few to rightfully claim so.

User Image insiderbuyingselling Posted - 02/21/24

$IQV new insider selling: 1000 shares. http://insiderbuyingselling.com/?t=IQV

User Image Stock_Titan Posted - 02/21/24

$IQV IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024 https://www.stocktitan.net/news/IQV/iqvia-cfo-ron-bruehlman-to-speak-at-citi-s-unplugged-medtech-and-50kn87jikktf.html

User Image wealthwithstocks Posted - 02/15/24

$IQV Nice jump. We continue to like the stock. https://app.ziggma.com/securities/IQV

User Image Doozio Posted - 02/14/24

$IQV look at that 🧠⏰ bahhhhtom. No such thing as a bull mkts thou YO! 🍿

User Image Doozio Posted - 02/14/24

$IQV chop chop huckleberries…🐒🍌🧠⏰

User Image Yaloo159 Posted - 02/14/24

Bearish Alert for $IQV IQVIA HOLDINGS INC

Analyst Ratings
Truist Securities Buy Feb 27, 24
Leerink Partners Outperform Feb 26, 24
Evercore ISI Group Market Outperform Feb 15, 24
UBS Buy Feb 15, 24
Baird Neutral Feb 15, 24
Barclays Overweight Feb 15, 24
Guggenheim Neutral Feb 15, 24
BTIG Buy Feb 13, 24
Barclays Overweight Jan 25, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Knightly Kevin C See Remarks See Remarks Dec 01 Sell 214.44 13,117 2,812,809 7,347 12/05/23
Knightly Kevin C See Remarks See Remarks Dec 01 Option 62.53 18,491 1,156,242 20,464 12/05/23
Panagos Constantinos See Remarks See Remarks Sep 19 Sell 208.66 27,317 5,699,965 33,017 09/21/23
Panagos Constantinos See Remarks See Remarks Sep 19 Option 143.14 26,186 3,748,264 40,436 09/21/23
Knightly Kevin C See Remarks See Remarks Jun 05 Sell 201.89 5,820 1,175,000 06/07/23
Knightly Kevin C See Remarks See Remarks May 26 Sell 198.66 1 199 05/31/23
Sherbet Eric See Remarks See Remarks Feb 13 Sell 230 1,000 230,000 17,053 02/15/23
Bruehlman Ronald E See Remarks See Remarks Jul 20 Buy 245.32 13 3,189 20,355 02/14/22